Alexandria Real Estate Equities Inc vs Baxter International Inc — how do they compare? Alexandria Real Estate Equities Inc trades at $48.29 (market cap $8.28B), while Baxter International Inc trades at $27.18 (market cap $14.27B). The key difference: Baxter International Inc is the larger of the two by market cap, and Alexandria Real Estate Equities Inc pays the higher dividend (5.99%). Which is the better fit depends on your goals.
| ARE | BAX | |
|---|---|---|
Market Cap | $8.28B | $14.27B |
Sector | Real Estate | Health |
52-Week High | $87.45 | $28.35 |
52-Week Low | $40.41 | $15.80 |
Enterprise Value | $20.98B | $21.79B |
Dividend Yield | 5.99% | 0.14% |
Signals from Pluang's Aura AI — not financial advice
Alexandria Real Estate Equities (ARE) trades at $48.01, down 0.7% on the day, with a bearish technical signal and mixed fundamentals. The stock shows negative profitability with a net income margin of -37.12% and ROE of -6.29% for 2025, though it maintains a strong gross margin of 67.28%. Recent Q2 2026 earnings missed EPS expectations but beat on FFO, with leasing momentum improving. The current price is near the analyst low target of $48.00, with support at $47 and resistance at $49.
Outlook remains cautious due to persistent net losses and high debt, but a 36% analyst buy rating and recent institutional acquisitions suggest potential recovery if leasing trends and FFO guidance hold. Key risks include occupancy pressures, legal scrutiny, and macroeconomic sensitivity. The stock presents a speculative opportunity for value investors betting on a real estate turnaround.
Baxter International (BAX) trades at $27.09, down 2.48% today but showing strong technical momentum with bullish moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.56, beating expectations by 53%, and raised full-year guidance. Despite negative net margins and elevated P/E ratio of 87.85, improving operational performance and positive cash flow projections for 2026 suggest potential turnaround.
The stock presents a mixed outlook with strong technical momentum and recent operational improvements offset by valuation concerns and profitability challenges. Key opportunities include continued execution on raised guidance and debt reduction efforts, while risks center on margin pressure and high debt levels. Analyst consensus leans neutral with 55.55% hold ratings and $25.43 price target below current levels.
Trailing returns across standard periods
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
Read more on ARE →Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →